VMP 16174811000001103

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Pramipexole 3.15mg modified-release tablets
BNF code 0409010W0AAAIAI
Virtual Therapeutic Moiety Pramipexole
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Pramipexole dihydrochloride monohydrate
Basis of pharmaceutical strength Based on Base Substance
Basis of strength substance identifier 386852009
Strength value numerator 3.150
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tabletmodified-release.oral
Dose Form
Formulation Modified-release tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Mirapexin 3.15mg modified-release tablets (Boehringer Ingelheim Ltd)
Mirapexin 3.15mg modified-release tablets (CST Pharma Ltd)
Mirapexin 3.15mg modified-release tablets (Sigma Pharmaceuticals Plc)
Pipexus 3.15mg modified-release tablets (Ethypharm UK Ltd)
Pramipexole 3.15mg modified-release tablets (A A H Pharmaceuticals Ltd)
Pramipexole 3.15mg modified-release tablets (Alliance Healthcare (Distribution) Ltd)
Pramipexole 3.15mg modified-release tablets (Krka UK Ltd)
Pramipexole 3.15mg modified-release tablets (Medihealth (Northern) Ltd)
Pramipexole 3.15mg modified-release tablets (Teva UK Ltd)
Pramipexole 3.15mg modified-release tablets (Viatris UK Healthcare Ltd)
Pramipexole 3.15mg modified-release tablets (Zentiva Pharma UK Ltd)
Virtual Medicinal Product Packs
Pramipexole 3.15mg modified-release tablets 30 tablet

dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.

Feedback